
streamlining the drug discovery pipeline with AI and protein folding
Drug discovery has long been a slow, costly, and high‑stakes endeavor, often requiring more than ten years and enormous financial investment before a single therapy reaches the market. Breakthroughs in artificial intelligence and protein folding tools are now transforming this process by greatly enhancing how researchers interpret biological targets, craft potential drug molecules, and anticipate their effects. As these innovations advance, development timelines are shrinking, expenses are decreasing, and therapeutic possibilities once considered unattainable are becoming viable.The Central Role of Protein Structure in Drug DiscoveryMost drugs work by binding to proteins and altering their activity. To design effective molecules, researchers…



